Stock Analysis

Top Growth Companies With Strong Insider Ownership November 2024

Published

In the midst of a busy earnings season, global markets have experienced volatility with major indices generally finishing lower, as growth stocks lagged behind value shares. Despite these fluctuations, companies with high insider ownership often signal strong confidence from those closest to the business, making them compelling considerations for investors seeking stability and potential growth in uncertain times.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)17.3%21.1%
Archean Chemical Industries (NSEI:ACI)22.9%34%
Kirloskar Pneumatic (BSE:505283)30.3%26.3%
People & Technology (KOSDAQ:A137400)16.4%35.6%
Laopu Gold (SEHK:6181)36.4%33%
Alkami Technology (NasdaqGS:ALKT)11.2%98.6%
Adveritas (ASX:AV1)21.2%144.2%
Plenti Group (ASX:PLT)12.8%107.6%
EHang Holdings (NasdaqGM:EH)32.8%81.4%
UTI (KOSDAQ:A179900)33.1%134.6%

Click here to see the full list of 1538 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Raytron TechnologyLtd (SHSE:688002)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Raytron Technology Co., Ltd. specializes in the R&D, design, manufacturing, and sales of uncooled infrared imaging and MEMS sensor technology in China, with a market cap of CN¥21.62 billion.

Operations: Raytron Technology Co., Ltd. generates its revenue primarily from the development and sale of uncooled infrared imaging and MEMS sensor technology in China.

Insider Ownership: 26.8%

Raytron Technology Ltd. has shown strong growth with earnings increasing by 14.4% over the past year and revenue forecasted to grow at 21.8% annually, outpacing the market average. Recent earnings reports indicate a rise in net income to CNY 483.4 million for the first nine months of 2024, up from CNY 386.89 million last year. The company is trading at a favorable price-to-earnings ratio of 36.5x compared to industry peers, despite recent share price volatility and completed buybacks totaling CNY 49.43 million.

SHSE:688002 Earnings and Revenue Growth as at Nov 2024

Suzhou Zelgen BiopharmaceuticalsLtd (SHSE:688266)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Suzhou Zelgen Biopharmaceuticals Co., Ltd. is a company focused on the development and commercialization of innovative biopharmaceutical products, with a market cap of CN¥16.66 billion.

Operations: The company's revenue is primarily generated from its pharmaceuticals segment, amounting to CN¥488.45 million.

Insider Ownership: 29.4%

Suzhou Zelgen Biopharmaceuticals has demonstrated significant revenue growth, with sales reaching CNY 384.12 million for the first nine months of 2024, up from CNY 282.1 million a year earlier. Despite a net loss reduction to CNY 97.9 million from CNY 202.09 million, the company is trading at about half its estimated fair value and is expected to become profitable within three years, with revenue projected to grow substantially above market rates at nearly 60% annually.

SHSE:688266 Earnings and Revenue Growth as at Nov 2024

Puya Semiconductor (Shanghai) (SHSE:688766)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Puya Semiconductor (Shanghai) Co., Ltd. designs and sells non-volatile memory chips and derivative chips based on memory chips in China and internationally, with a market cap of CN¥8.40 billion.

Operations: The company generates revenue of CN¥1.73 billion from its Integrated Circuit segment.

Insider Ownership: 23.8%

Puya Semiconductor (Shanghai) has shown robust growth, with sales reaching CNY 1.37 billion for the first nine months of 2024, up from CNY 767.14 million a year earlier, and net income turning positive at CNY 224.75 million. Despite high share price volatility recently, the company is trading at a favorable price-to-earnings ratio compared to the CN market and is expected to see substantial revenue growth of over 24% annually in coming years.

SHSE:688766 Ownership Breakdown as at Nov 2024

Make It Happen

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com